IOL Chemicals and Pharmaceuticals Limited (IOLCP.NS)
INR 61.65
(3.88%)
INR 61.65
(3.88%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.2 Billion INR | -37.98% |
| 2022 | 4.9 Billion INR | 37.97% |
| 2021 | 3.55 Billion INR | 32.25% |
| 2020 | 2.68 Billion INR | 11.72% |
| 2019 | 2.4 Billion INR | 14.16% |
| 2018 | 2.1 Billion INR | 34.86% |
| 2017 | 1.56 Billion INR | 5.77% |
| 2016 | 1.47 Billion INR | 1.87% |
| 2015 | 1.45 Billion INR | 17.81% |
| 2014 | 1.23 Billion INR | -4.89% |
| 2013 | 1.29 Billion INR | 4.52% |
| 2012 | 1.23 Billion INR | 0.09% |
| 2011 | 1.23 Billion INR | 105.48% |
| 2010 | 602.16 Million INR | 57.49% |
| 2009 | 382.36 Million INR | 36.14% |
| 2008 | 280.86 Million INR | -8.98% |
| 2007 | 308.56 Million INR | 97.2% |
| 2006 | 156.46 Million INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 618.5 Million INR | -35.49% |
| 2023 FY | 3.04 Billion INR | -37.98% |
| 2023 Q1 | 1.4 Billion INR | 10.91% |
| 2023 Q2 | 1.43 Billion INR | 2.23% |
| 2023 Q3 | 1.36 Billion INR | -4.77% |
| 2023 Q4 | 822.3 Million INR | -39.73% |
| 2022 FY | 4.9 Billion INR | 37.97% |
| 2022 Q2 | 1.18 Billion INR | -6.03% |
| 2022 Q3 | 1.2 Billion INR | 2.0% |
| 2022 Q1 | 1.25 Billion INR | 88.41% |
| 2022 Q4 | 1.26 Billion INR | 4.92% |
| 2021 Q1 | 836.1 Million INR | 113.84% |
| 2021 Q2 | 991.8 Million INR | 18.62% |
| 2021 FY | 3.55 Billion INR | 32.25% |
| 2021 Q3 | 1.06 Billion INR | 6.92% |
| 2021 Q4 | 666.9 Million INR | -37.11% |
| 2020 Q3 | 793.7 Million INR | -2.31% |
| 2020 FY | 2.68 Billion INR | 11.72% |
| 2020 Q1 | 691.1 Million INR | 231.78% |
| 2020 Q4 | 391 Million INR | -50.74% |
| 2020 Q2 | 812.5 Million INR | 17.57% |
| 2019 Q2 | 724.8 Million INR | -4.53% |
| 2019 Q3 | 714 Million INR | -1.49% |
| 2019 Q4 | 208.3 Million INR | -70.83% |
| 2019 FY | 2.4 Billion INR | 14.16% |
| 2019 Q1 | 759.2 Million INR | 405.12% |
| 2018 Q4 | 150.3 Million INR | -79.56% |
| 2018 Q2 | 671 Million INR | 17.45% |
| 2018 FY | 2.1 Billion INR | 34.86% |
| 2018 Q1 | 571.3 Million INR | 13.65% |
| 2018 Q3 | 735.5 Million INR | 9.61% |
| 2017 Q1 | 436.7 Million INR | 8.07% |
| 2017 FY | 1.56 Billion INR | 5.77% |
| 2017 Q4 | 502.7 Million INR | -3.95% |
| 2017 Q3 | 523.4 Million INR | 13.51% |
| 2017 Q2 | 461.1 Million INR | 5.59% |
| 2016 FY | 1.47 Billion INR | 1.87% |
| 2016 Q2 | 395.8 Million INR | 6.88% |
| 2016 Q3 | 410.6 Million INR | 3.74% |
| 2016 Q1 | 370.3 Million INR | 5.24% |
| 2016 Q4 | 404.1 Million INR | -1.58% |
| 2015 Q2 | 366.91 Million INR | -1.36% |
| 2015 Q4 | 351.86 Million INR | -2.18% |
| 2015 Q1 | 371.98 Million INR | 16.08% |
| 2015 Q3 | 359.71 Million INR | -1.96% |
| 2015 FY | 1.45 Billion INR | 17.81% |
| 2014 Q4 | 320.46 Million INR | -1.64% |
| 2014 Q3 | 325.79 Million INR | 12.02% |
| 2014 Q1 | 294.06 Million INR | -2.0% |
| 2014 FY | 1.23 Billion INR | -4.89% |
| 2014 Q2 | 290.83 Million INR | -1.1% |
| 2013 Q4 | 300.05 Million INR | -11.06% |
| 2013 Q2 | 357.27 Million INR | 21.72% |
| 2013 Q1 | 293.52 Million INR | -14.04% |
| 2013 Q3 | 337.38 Million INR | -5.57% |
| 2013 FY | 1.29 Billion INR | 4.52% |
| 2012 Q4 | 341.45 Million INR | 16.79% |
| 2012 Q3 | 292.35 Million INR | -3.16% |
| 2012 Q2 | 301.89 Million INR | -0.29% |
| 2012 Q1 | 302.76 Million INR | 0.0% |
| 2012 FY | 1.23 Billion INR | 0.09% |
| 2011 FY | 1.23 Billion INR | 105.48% |
| 2010 FY | 602.16 Million INR | 57.49% |
| 2009 FY | 382.36 Million INR | 36.14% |
| 2008 FY | 280.86 Million INR | -8.98% |
| 2007 FY | 308.56 Million INR | 97.2% |
| 2006 FY | 156.46 Million INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | 86.131% |
| Hester Biosciences Limited | 908.84 Million INR | -142.177% |
| Aarti Drugs Limited | 1.16 Billion INR | -88.526% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | 28.409% |
| Albert David Limited | 1.02 Billion INR | -114.492% |
| Alembic Limited | 872.45 Million INR | -152.276% |
| Alkem Laboratories Limited | 32.83 Billion INR | 93.297% |
| Bafna Pharmaceuticals Limited | 455.58 Million INR | -383.115% |
| Bajaj HealthCare Limited | 985.34 Million INR | -123.374% |
| Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -32172.727% |
| Brooks Laboratories Limited | 51.18 Million INR | -4200.508% |
| Eris Lifesciences Limited | 4.94 Billion INR | 55.472% |
| FDC Limited | 3.49 Billion INR | 37.11% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | 81.092% |
| Gufic Biosciences Limited | 1.18 Billion INR | -85.49% |
| Hikal Limited | 4.46 Billion INR | 50.692% |
| Ind-Swift Limited | 946.56 Million INR | -132.524% |
| Innova Captab Limited | 931.03 Million INR | -136.405% |
| Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -401.881% |
| Jubilant Pharmova Limited | 14.45 Billion INR | 84.772% |
| Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -104.899% |
| Lupin Limited | 125.09 Billion INR | 98.241% |
| Mangalam Drugs & Organics Limited | 162.22 Million INR | -1256.732% |
| Medico Remedies Limited | 59.67 Million INR | -3588.312% |
| Morepen Laboratories Limited | 1.98 Billion INR | -10.745% |
| Nectar Lifesciences Limited | 932.7 Million INR | -135.982% |
| Orchid Pharma Limited | 800.77 Million INR | -174.86% |
| Procter & Gamble Health Limited | 2.99 Billion INR | 26.521% |
| RPG Life Sciences Limited | 1.63 Billion INR | -34.577% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -433.67% |
| Sigachi Industries Limited | 579.88 Million INR | -279.557% |
| Solara Active Pharma Sciences Limited | 2.55 Billion INR | 13.825% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -56.902% |
| Themis Medicare Limited | 1.12 Billion INR | -95.506% |
| Unichem Laboratories Limited | 6.72 Billion INR | 67.276% |
| Vaishali Pharma Limited | 84.02 Million INR | -2519.334% |
| Wanbury Limited | 978.96 Million INR | -124.829% |
| Windlas Biotech Limited | 1 Billion INR | -118.676% |
| ZIM Laboratories Limited | 1.01 Billion INR | -117.263% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -3.616% |
| Ipca Laboratories Limited | 18.98 Billion INR | 88.408% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 98.572% |
| Venus Remedies Limited | 1.91 Billion INR | -14.858% |
| Sakar Healthcare Limited | 204.07 Million INR | -978.504% |
| Aurobindo Pharma Limited | 55.65 Billion INR | 96.045% |
| Divi's Laboratories Limited | 14.17 Billion INR | 84.467% |
| AstraZeneca Pharma India Limited | 2.47 Billion INR | 11.017% |
| Mankind Pharma Limited | 29.27 Billion INR | 92.481% |
| Sequent Scientific Limited | 2.9 Billion INR | 24.151% |
| Laurus Labs Limited | 11.9 Billion INR | 81.519% |
| Neuland Laboratories Limited | 2.92 Billion INR | 24.874% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 85.121% |
| Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 95.312% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 98.242% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -5.108% |
| Wockhardt Limited | 8.48 Billion INR | 74.045% |
| Bal Pharma Limited | 555.62 Million INR | -296.13% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 97.704% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -55.085% |
| Par Drugs and Chemicals Limited | 58.28 Million INR | -3676.076% |
| Caplin Point Laboratories Limited | 2.17 Billion INR | -1.219% |
| Shilpa Medicare Limited | 3.33 Billion INR | 33.987% |
| Valiant Laboratories Limited | 138.02 Million INR | -1494.592% |
| Ajanta Pharma Limited | 30.46 Billion INR | 92.775% |
| Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -15385.823% |
| Granules India Limited | 10.31 Billion INR | 78.658% |
| Medicamen Biotech Limited | 335.16 Million INR | -556.688% |
| Syncom Formulations (India) Limited | 345.63 Million INR | -536.803% |
| Piramal Enterprises Limited | 63.65 Billion INR | 96.542% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | 89.726% |
| NATCO Pharma Limited | 10.05 Billion INR | 78.117% |
| Suven Life Sciences Limited | 109.75 Million INR | -1905.467% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -4668.611% |
| Strides Pharma Science Limited | 9.16 Billion INR | 75.978% |
| Indoco Remedies Limited | 12.06 Billion INR | 81.751% |
| Alpa Laboratories Limited | 127.38 Million INR | -1627.901% |
| Lasa Supergenerics Limited | 291.17 Million INR | -655.905% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 28.465% |